Eisenmenger’s syndrome screening: Difference between revisions
Jump to navigation
Jump to search
| Line 9: | Line 9: | ||
* There are currently no guidelines on using [[echocardiography]] to screen patients with [[CHD]] for the presence of [[Pulmonary hypertension|pulmonary arterial hypertension]]. | * There are currently no guidelines on using [[echocardiography]] to screen patients with [[CHD]] for the presence of [[Pulmonary hypertension|pulmonary arterial hypertension]]. | ||
* However, some parameters are recommended as pedictive | * However, some parameters are recommended as pedictive for the development of [[Pulmonary hypertension|pulmonary arterial hypertension]]<ref name="pmid30497564">{{cite journal| author=Dimopoulos K, Condliffe R, Tulloh RMR, Clift P, Alonso-Gonzalez R, Bedair R et al.| title=Echocardiographic Screening for Pulmonary Hypertension in Congenital Heart Disease: JACC Review Topic of the Week. | journal=J Am Coll Cardiol | year= 2018 | volume= 72 | issue= 22 | pages= 2778-2788 | pmid=30497564 | doi=10.1016/j.jacc.2018.08.2201 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=30497564 }}</ref>. | ||
**Peak tricuspid regurgitation velocity | **Peak [[tricuspid regurgitation]] velocity | ||
**Ventricular basal diameter ratio | **Ventricular basal diameter ratio | ||
**Systolic and/or diastolic ventricular eccentricity index. | **Systolic and/or diastolic ventricular eccentricity index. | ||
**RV outflow Doppler acceleration time | **RV outflow Doppler acceleration time | ||
**Pulmonary artery diameter | **[[Pulmonary artery]] diameter | ||
**Inferior vena cava inspiratory collapse | **Inferior vena cava inspiratory collapse | ||
Revision as of 04:41, 27 January 2020
|
Eisenmenger’s syndrome Microchapters |
|
Diagnosis |
|---|
|
Eisenmenger’s syndrome ACC/AHA Guidelines for Evaluation of Patients |
|
Treatment |
|
Eisenmenger’s syndrome screening On the Web |
|
American Roentgen Ray Society Images of Eisenmenger’s syndrome screening |
|
Risk calculators and risk factors for Eisenmenger’s syndrome screening |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Abdelrahman Ibrahim Abushouk, MD[2]
Overview
According to the [guideline name], screening for [disease name] by [test 1] is recommended every [duration] among patients with [condition 1], [condition 2], and [condition 3].
Screening
- There are currently no guidelines on using echocardiography to screen patients with CHD for the presence of pulmonary arterial hypertension.
- However, some parameters are recommended as pedictive for the development of pulmonary arterial hypertension[1].
- Peak tricuspid regurgitation velocity
- Ventricular basal diameter ratio
- Systolic and/or diastolic ventricular eccentricity index.
- RV outflow Doppler acceleration time
- Pulmonary artery diameter
- Inferior vena cava inspiratory collapse
References
- ↑ Dimopoulos K, Condliffe R, Tulloh RMR, Clift P, Alonso-Gonzalez R, Bedair R; et al. (2018). "Echocardiographic Screening for Pulmonary Hypertension in Congenital Heart Disease: JACC Review Topic of the Week". J Am Coll Cardiol. 72 (22): 2778–2788. doi:10.1016/j.jacc.2018.08.2201. PMID 30497564.